Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Preserving and handling native data in hybrid object trees
Point-of-sale cart
Electronic communication device
Wireless communication power control
Food safety printer
Low power voltage controlled oscillator (VCO)
Managing deduplication density
  Randomly Featured Patents
Apoptosis-inducing factor
Displaying electronic documents with substitute fonts
Reproducing apparatus reproducing data from a recording medium having a preformatted address area at a starting position of each sector
Frame/multiframe structure FDMA system and corresponding signal
Instrument tray and disposable receptacle having alternative locking means
Eyepiece lens, objective lens, and optical apparatus having them
Variable resonator, variable bandwidth filter, and electric circuit device
Arrow rest
Carbon black method
Free radically cured cold-box binders containing an alkyl silicate